Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Szubin, Adam J.	en_US
dc.date.accessioned	2012-06-07T03:22:33Z
dc.date.issued	1999	en_US
dc.identifier.citation	Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products (1999 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846773
dc.description.abstract	There is a great need for the increased development and use of nicotine dependence products (NDPs) in this country. A creative regulatory approach, such as the FDA brought to tobacco regulation, could do an enormous amount of good. In the field of NDPs, as in every area of drug regulation, a new regulatory approach will bring with it costs and benefits. As our knowledge advances, the FDA should not be slow to adopt the same aggressive yet flexible approach to NDPs that it has adopted towards tobacco. It should be a short-term goal for the FDA to ensure that â€&oelig;each decision to smoke should present an equal opportunity not to smoke and an equal opportunity to get help.â€	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	tobacco	en
dc.subject	nicotine	en
dc.subject	FDA	en
dc.subject	regulation	en
dc.subject	nicotine dependence products	en
dc.title	Levelling the Playing Field: the FDA's Regulation of Nicotine Dependence Products	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T03:22:33Z